Full-Time

Head of Biotherapeutics – Sr. Director or VP Level

Confirmed live in the last 24 hours

Manifold Bio

Manifold Bio

11-50 employees

Designs precision biologics using in vivo methods

Biotechnology
Healthcare

Senior, Expert

Boston, MA, USA

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Experience taking multiple molecules through IND and into the clinic
  • Deep understanding of protein production techniques, including mammalian cell culture and purification/characterization approaches
  • Expertise in novel biotherapeutic modalities, across a range of formats
  • Extensive experience leading cross-functional teams
  • Experience with complex biologics (e.g. multispecifics)
Responsibilities
  • Leading internal protein sciences and protein engineering teams
  • Own strategy for early stage de-risking and optimization of lead molecules
  • Own strategy for developability assessment
  • Work with internal and external team members to ensure cost-effective and timely drug manufacture
  • Build internal expertise on cutting-edge protein engineering techniques
  • Guide prioritization for internal protein generation efforts, balancing between screening and lead characterization
  • Build an R&D-to-development pipeline for lead candidates
  • Utilize state of the art techniques to drive the development of best-in-class therapeutic candidates
  • Stay up to speed on cutting edge research and industry standards for protein therapeutics

Manifold Bio focuses on creating precision biologics for the pharmaceutical industry. Their main product is an in vivo drug design platform, which allows for drug testing within living organisms rather than in laboratory settings. This platform utilizes mCodes™ technology, a unique protein barcoding system that enables the simultaneous study of multiple proteins in one experiment. This capability is especially beneficial for testing complex biologics, which are large molecule drugs derived from living organisms. Manifold Bio stands out from competitors by being the first to offer this in vivo drug design approach. The company's goal is to expand their platform and collaborate with other pharmaceutical companies to develop new therapeutics.

Company Stage

Series A

Total Funding

$58.8M

Headquarters

Boston, Massachusetts

Founded

2020

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Raised $40M in Series A funding, indicating strong market interest.
  • Major investors like Tencent and Horizons Ventures show confidence in their innovation.
  • Their technology addresses the in vivo testing bottleneck in drug development.

What critics are saying

  • Emerging competition in protein barcoding could threaten their market position.
  • Rapid AI advancements may outpace their current platform capabilities.
  • Regulatory challenges could delay multiplexed in vivo testing approvals.

What makes Manifold Bio unique

  • Manifold Bio's mCodes™ technology enables multiplexed protein analysis in vivo.
  • Their platform allows simultaneous testing of multiple molecules in living systems.
  • They are pioneering in vivo biologics design, a first in the pharmaceutical industry.

Help us improve and share your feedback! Did you find this helpful?